Clinical Trial Update: A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease. [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial update for ER2001 Injection in early manifest Huntington's disease, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• ER2001

Snippet

Sponsor: ExoRNA Bioscience | Conditions: Huntington Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING